Science

Jun 14, 2025, 11:49

Myeloma Paper of the Day, June 14th, suggested by Robert Orlowski

Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma Paper of the Day: Retrospective study of AL amyloidosis pts (n=130) with liver involvement finds median time to hepatic response (HepR) 21.5 mos; baseline ALP ≥4xULN predicted HepR; HemR, kappa isotype and front-line ASCT also predicted HepR.”

Title: Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survival

Authors: Matthew J. Rees, Nadia Toumeh, Angela Dispenzieri, Morie Gertz, Binoy Yohannan, Suheil Albert Atallah-Yunes, Prashant Kapoor, Taxiarchis Kourelis, Nelson Leung, Suzanne Hayman, Francis Buadi, David Dingli, Joselle Cook, Rahma Warsame, Moritz Binder, Wilson Gonsalves, S. Vincent Rajkumar, Shaji Kumar, Eli Muchtar

You can read the Full Article in Amyloid.

More posts featuring Robert Orlowski.

AL Amyloidosis Angela Dispenzieri Binoy Yohannan cancer David Dingli Eli Muchtar Francis Buadi Joselle Cook Matthew J Rees Morie Gertz Moritz Binder Myeloma Myeloma Paper of the Day Nadia Toumeh Nelson Leung OncoDaily Oncology Prashant Kapoor Rahma Warsame Robert Orlowski S Vincent Rajkumar Shaji Kumar Suheil Albert Atallah-Yunes Suzanne Hayman Taxiarchis Kourelis Wilson Gonsalves

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More

Agenus Enters New Era With $141M Zydus Deal Signaling Strategic Transformation in Immuno-Oncology

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology

How Artificial Intelligence Is Transforming Cancer Care in 2025: Diagnosis, Treatment, Clinical Trials, and Screening